Compare Archer-Daniels-Midland Co (ADM) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer-Daniels-Midland Co vs Citius Pharmaceuticals Inc — how do they compare? Archer-Daniels-Midland Co trades at $80.5 (market cap $38.78B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Archer-Daniels-Midland Co is far larger — about 1938× Citius Pharmaceuticals Inc's market cap, and Archer-Daniels-Midland Co pays a 2.59% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| ADM | CTXR | |
|---|---|---|
Market Cap | $38.78B | $20.01M |
Sector | Consumer Staples | Health |
52-Week High | $87.32 | $1.82 |
52-Week Low | $56.00 | $0.48 |
Enterprise Value | $47.03B | $16.23M |
Dividend Yield | 2.59% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Archer-Daniels-Midland Co
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
